Literature DB >> 18441039

Can exercise limits prevent post-exertional malaise in chronic fatigue syndrome? An uncontrolled clinical trial.

Jo Nijs1, Freya Almond, Pascale De Becker, Steven Truijen, Lorna Paul.   

Abstract

OBJECTIVE: It was hypothesized that the use of exercise limits prevents symptom increases and worsening of their health status following a walking exercise in people with chronic fatigue syndrome.
DESIGN: An uncontrolled clinical trial (semi-experimental design).
SETTING: Outpatient clinic of a university department.
SUBJECTS: Twenty-four patients with chronic fatigue syndrome.
INTERVENTIONS: Subjects undertook a walking test with the two concurrent exercise limits. Each subject walked at an intensity where the maximum heart rate was determined by heart rate corresponding to the respiratory exchange ratio = 1.0 derived from a previous submaximal exercise test and for a duration calculated from how long each patient felt they were able to walk. MAIN OUTCOME MEASURES: The Short Form 36 Health Survey or SF-36, the Chronic Fatigue Syndrome Symptom List, and the Chronic Fatigue Syndrome -Activities and Participation Questionnaire were filled in prior to, immediately after and 24 hours after exercise.
RESULTS: The fatigue increase observed immediately post-exercise (P= 0.006) returned to pre-exercise levels 24 hours post-exercise. The increase in pain observed immediately post-exercise was retained at 24 hours post-exercise (P=0.03). Fourteen of the 24 subjects experienced a clinically meaningful change in bodily pain (change of SF-36 bodily pain score > or =10); 6 indicated that the exercise bout had slightly worsened their health status, and 2 had a clinically meaningful decrease in vitality (change of SF-36 vitality score > or =20). There was no change in activity limitations/participation restrictions.
CONCLUSION: It was shown that the use of exercise limits (limiting both the intensity and duration of exercise) prevents important health status changes following a walking exercise in people with chronic fatigue syndrome, but was unable to prevent short-term symptom increases.

Entities:  

Mesh:

Year:  2008        PMID: 18441039     DOI: 10.1177/0269215507084410

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  10 in total

1.  Differences in ME and CFS Symptomology in Patients with Normal and Abnormal Exercise Test Results.

Authors:  Stephanie L McManimen; Leonard A Jason
Journal:  Int J Neurol Neurother       Date:  2017-03-21

2.  Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls.

Authors:  Andrea T White; Alan R Light; Ronald W Hughen; Timothy A Vanhaitsma; Kathleen C Light
Journal:  Psychosom Med       Date:  2011-12-30       Impact factor: 4.312

3.  Measuring substantial reductions in functioning in patients with chronic fatigue syndrome.

Authors:  Leonard Jason; Molly Brown; Meredyth Evans; Valerie Anderson; Athena Lerch; Abigail Brown; Jessica Hunnell; Nicole Porter
Journal:  Disabil Rehabil       Date:  2010-07-09       Impact factor: 3.033

4.  Physical and psychological correlates of fatigue and physical function: a Collaborative Health Outcomes Information Registry (CHOIR) study.

Authors:  John A Sturgeon; Beth D Darnall; Ming-Chih J Kao; Sean C Mackey
Journal:  J Pain       Date:  2014-12-20       Impact factor: 5.820

Review 5.  Quality and acceptability of patient-reported outcome measures used in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review.

Authors:  Kirstie L Haywood; Sophie Staniszewska; Sarah Chapman
Journal:  Qual Life Res       Date:  2011-05-18       Impact factor: 4.147

6.  Post-exertional malaise in veterans with gulf war illness.

Authors:  Jacob B Lindheimer; Aaron J Stegner; Glenn R Wylie; Jacquelyn C Klein-Adams; Neda E Almassi; Jacob V Ninneman; Stephanie M Van Riper; Ryan J Dougherty; Michael J Falvo; Dane B Cook
Journal:  Int J Psychophysiol       Date:  2019-11-28       Impact factor: 2.997

7.  Lifestyle-oriented non-pharmacological treatments for fibromyalgia: a clinical overview and applications with home-based technologies.

Authors:  Fred Friedberg; David A Williams; William Collinge
Journal:  J Pain Res       Date:  2012-10-25       Impact factor: 3.133

8.  Catalase S-Glutathionylation by NOX2 and Mitochondrial-Derived ROS Adversely Affects Mice and Human Neutrophil Survival.

Authors:  Sheela Nagarkoti; Megha Dubey; Samreen Sadaf; Deepika Awasthi; Tulika Chandra; Kumaravelu Jagavelu; Sachin Kumar; Madhu Dikshit
Journal:  Inflammation       Date:  2019-12       Impact factor: 4.657

Review 9.  Myalgic Encephalomyelitis: Symptoms and Biomarkers.

Authors:  Leonard A Jason; Marcie L Zinn; Mark A Zinn
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

10.  Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey.

Authors:  Lily Chu; Ian J Valencia; Donn W Garvert; Jose G Montoya
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.